Wird geladen...
Could ketamine be the answer to treating treatment-resistant major depressive disorder?
Major depressive disorder (MDD) is a common, serious, debilitating condition affecting 350 million people worldwide, which remains to be unsatisfactorily treated with 53% of patients still complaining of symptoms after completing their courses with the correct dosage. Ketamine, which was approved by...
Gespeichert in:
| Veröffentlicht in: | Gen Psychiatr |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7437682/ https://ncbi.nlm.nih.gov/pubmed/32875273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gpsych-2020-100227 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|